Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorRutgers, The State University of New Jersey
About this trial
The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.
Eligibility criteria
Qualifiers
English-speaking
Age ≥18
Currently on methadone; and 4) currently smoke cigarettes.
Disqualifiers
Severe cognitive impairment (score >23 on Mini Mental Status Exam) or psychosis (positive SCID Psychotic Screen)
Suicidal risk (score ≥7 on Suicidal Behaviors Questionnaire)
Inability to attend or fully participate in intervention sessions or assessments
Previous formal mindfulness training (e.g., MBSR, MBRP) or MORE (from the R21 or R33
Trial design
Treatments tested in this trial
- MORE and MI and NRT
- MORE and No MI and NRT
- Support Group and MI and NRT
- Support Group and No MI and NRT
Treatment groups
420 Participants
are divided into 4 treatment groupsSponsors and collaborators
Rutgers, The State University of New Jersey
Lead sponsor
University of Utah
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov